BHCM
MGNX icon

Brevan Howard Capital Management’s MacroGenics MGNX Stock Holding History

Brevan Howard Capital Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-32,079
Closed -$92.7K – 2388
2026
Q1 		$92.7K Buy
+32,079
New +$68.4K ﹤0.01% 2041
2024
Q4 		– Sell
-41,706
Closed -$137K – 1285
2024
Q3 		$137K Buy
41,706
+20,184
+94% +$78.6K ﹤0.01% 1046
2024
Q2 		$91.5K Buy
+21,522
New +$210K ﹤0.01% 971

Other funds holding MGNX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Brevan Howard Capital Management's MGNX Position: Q2 2026 in Review

Brevan Howard Capital Management sold out of MacroGenics (MGNX) in Q2 2026, closing a stake of 32,079 shares — an estimated $92.7K sold.

Brevan Howard Capital Management first reported a position in MGNX in Q2 2024 and held it in 3 quarters. The position peaked at $137K in Q3 2024. 122 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

  • Brevan Howard Capital Management reported no remaining MacroGenics position as of Q2 2026 after selling out during the quarter.
  • Brevan Howard Capital Management sold 32,079 MacroGenics shares in Q2 2026, an estimated $92.7K.
  • Brevan Howard Capital Management first reported a position in MacroGenics in Q2 2024 and held it in 3 quarters.
  • Brevan Howard Capital Management's MacroGenics position peaked at $137K in Q3 2024.
  • 122 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.